News
Publications
Read more about Nycomed in our
Company Brochure 2009 
Annual Report 2008
Last quaterly report
Where we work
Nycomed is present in over 50 countries.

Find your local Nycomed website and office and the way to our headquarters in Zurich, Switzerland.
 Soft-Relaunch Pictures
 Nycomed is a privately owned global pharmaceutical company with a differentiated portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. An extensive range of OTC products completes the portfolio.

Its R&D is built to be open for partnerships beyond its core areas in inflammatory, respiratory diseases and pain as in-licensing is a cornerstone in the company’s growth strategy.
 


The company employs 12,000 associates worldwide, and its products are available in more than 100 countries. It has strong platforms in Europe and in fast-growing markets such as Russia/CIS, and Latin America. While the US and Japan are commercialised through best-in-class partners, Nycomed will further strengthen its position in key Asian markets.

Headquartered in Zurich/Switzerland, the company generated in 2008 total sales of € 3.4 billion and an adjusted EBITDA of € 1.2 billion.

Disclaimer